Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc (ORGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 340,379
  • Shares Outstanding, K 130,915
  • Annual Sales, $ 468,060 K
  • Annual Income, $ 94,900 K
  • 60-Month Beta 1.65
  • Price/Sales 0.74
  • Price/Cash Flow 2.87
  • Price/Book 1.34
Trade ORGO with:

Options Overview Details

View History
  • Implied Volatility 87.60% ( -0.19%)
  • Historical Volatility 68.23%
  • IV Percentile 48%
  • IV Rank 28.79%
  • IV High 257.37% on 05/11/22
  • IV Low 18.95% on 09/19/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 28
  • Put/Call OI Ratio 1.37
  • Today's Open Interest 1,032
  • Open Int (30-Day) 948

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year 0.41
  • Growth Rate Est. (year over year) -85.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.23 +18.83%
on 11/10/22
3.32 -20.18%
on 11/08/22
-0.63 (-19.21%)
since 11/07/22
3-Month
2.23 +18.83%
on 11/10/22
3.75 -29.33%
on 09/12/22
-0.87 (-24.72%)
since 09/07/22
52-Week
2.23 +18.83%
on 11/10/22
10.62 -75.05%
on 12/08/21
-7.70 (-74.40%)
since 12/07/21

Most Recent Stories

More News
Organogenesis Holdings Inc. (ORGO) Q3 2022 Earnings Call Transcript

ORGO earnings call for the period ending September 30, 2022.

ORGO : 2.65 (+1.92%)
Organogenesis (ORGO) Lags Q3 Earnings and Revenue Estimates

Organogenesis (ORGO) delivered earnings and revenue surprises of -33.33% and 3.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ORGO : 2.65 (+1.92%)
TXMD : 6.01 (+11.30%)
Akebia Therapeutics (AKBA) Reports Q3 Loss, Tops Revenue Estimates

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -86.67% and 3.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

AKBA : 0.3000 (+5.26%)
ORGO : 2.65 (+1.92%)
Why Organogenesis Stock Is Tumbling Today

It didn't make as much money in the second quarter as investors were hoping.

ORGO : 2.65 (+1.92%)
Organogenesis Holdings Inc. (ORGO) Q2 2022 Earnings Call Transcript

ORGO earnings call for the period ending June 30, 2022.

ORGO : 2.65 (+1.92%)
Organogenesis (ORGO) Tops Q2 Earnings and Revenue Estimates

Organogenesis (ORGO) delivered earnings and revenue surprises of 12.50% and 0.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ORGO : 2.65 (+1.92%)
ATNM : 10.54 (+2.53%)
Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results

CANTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...

ORGO : 2.65 (+1.92%)
Select Medical (SEM) Misses Q2 Earnings and Revenue Estimates

Select Medical (SEM) delivered earnings and revenue surprises of -15.69% and 1.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

SEM : 23.47 (-3.30%)
ORGO : 2.65 (+1.92%)
Organogenesis (ORGO) Stock Jumps 5.3%: Will It Continue to Soar?

Organogenesis (ORGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

ORGO : 2.65 (+1.92%)
OPTN : 1.8900 (+8.00%)
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022

CANTON, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...

ORGO : 2.65 (+1.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

See More

Key Turning Points

3rd Resistance Point 2.80
2nd Resistance Point 2.74
1st Resistance Point 2.69
Last Price 2.65
1st Support Level 2.59
2nd Support Level 2.53
3rd Support Level 2.48

See More

52-Week High 10.62
Fibonacci 61.8% 7.42
Fibonacci 50% 6.43
Fibonacci 38.2% 5.43
Last Price 2.65
52-Week Low 2.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar